Cluster 750: female reproductive employing birth control feeding effective pregnant breast potential 
Cluster 878: excipient durvalumab hypersensitivity history tremelimumab medi known sgi substance component 
Cluster 2473: durvalumab tremelimumab dose female days monotherapy reproductive effective birth employ